SCHEMBL24178174

SCHEMBL24178174

CC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C=O)Cc1ccccc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CTSB P07858 3/20 0.58
ALDH1A1 P00352 1/20 0.54
CMA1 P23946 1/20 0.54
CTRC Q99895 1/20 0.54
CPA1 P15085 2/20 0.53
CPA2 P48052 2/20 0.53
CPA4 Q9UI42 2/20 0.53
CPB1 P15086 1/20 0.53
ACE2 Q9BYF1 1/20 0.53
PSMB5 P28074 1/20 0.53
PSMB2 P49721 1/20 0.53
CTSS P25774 1/20 0.52
CTSK P43235 1/20 0.52
GNPAT O15228 1/20 0.52
REN P00797 1/20 0.52
MME P08473 1/20 0.51
MMP1 P03956 1/20 0.51
MMP2 P08253 1/20 0.51
MMP3 P08254 1/20 0.51
CTSL P07711 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24178168 1.00 CTSB (0.58) CTSBALDH1A1CMA1CTRCCPA1
SCHEMBL7144589 0.98 CTSB (0.61) CTSBALDH1A1CMA1CTRCCPA1
SCHEMBL13706577 0.98 CTSB (0.61) CTSBALDH1A1CMA1CTRCCPA1
SCHEMBL24178166 0.94 CTSB (0.56) CTSBALDH1A1CMA1CTRCCPA1
SCHEMBL6248305 0.90 CTSB (0.55) CTSBALDH1A1CMA1CTRCCPA1
SCHEMBL25465177 0.88 CPA1 (0.50) CTSBALDH1A1CPA1CPA2CPA4
SCHEMBL25466140 0.88 CPA1 (0.50) CTSBALDH1A1CPA1CPA2CPA4
SCHEMBL8529180 0.88 KISS1R (0.53) CTSBALDH1A1CMA1CTRCCPA1
SCHEMBL24178171 0.88 CTSB (0.52) CTSBALDH1A1CMA1CTRCCPA1
SCHEMBL24178183 0.88 CTSB (0.52) CTSBALDH1A1CMA1CTRCCPA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11912742-B2 Heterologous production of leupeptin protease inhibitors and analogs thereof YALE UNIVERSITY (US) 2024-02-27 US disclosed
US-20220002354-A1 HETEROLOGOUS PRODUCTION OF LEUPEPTIN PROTEASE INHIBITORS AND ANALOGS THEREOF YALE UNIVERSITY 2022-01-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11912742-B2 Heterologous production of leupeptin protease inhibitors and analogs thereof LPXN, LAP3, PEPD CTSB 25/4885ALDH1A1 4762/4885CMA1 149/4885
US-20220002354-A1 HETEROLOGOUS PRODUCTION OF LEUPEPTIN PROTEASE INHIBITORS AND ANALOGS THEREOF LPXN, LAP3, PEPD CTSB 25/4885ALDH1A1 4762/4885CMA1 149/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.